Location History:
- Rottenburg, DE (2012 - 2017)
- Dettingen an der Erms, DE (2024)
Company Filing History:
Years Active: 2012-2025
Title: Oliver Planz: Innovator in Viral Disease Treatment
Introduction:
In the world of medical advancements, Oliver Planz has been a significant contributor in the field of viral disease treatment. Hailing from Rottenburg, Germany, Planz has made substantial contributions by inventing new methods and therapies to combat viral infections. With a focus on MEK inhibitors, his latest patents have shown promising results in the prevention and treatment of a wide range of virus-related diseases. Let's delve into his innovative work and notable collaborations.
Latest Patents:
Oliver Planz's latest patents revolve around MEK inhibitors and their efficacy in treating viral infections. The first patent, "MEK inhibitors in the treatment of virus diseases," highlights the use of MEK inhibitors in combination with neuraminidase inhibitor compounds to achieve therapeutic benefits. These inhibitors have the potential to prevent and treat viral infections, thus offering promising outcomes in virus-related diseases.
Another patent, "Compositions and methods for the prophylaxis or treatment of viral diseases," focuses on the use of active ingredients inhibiting cellular signal transduction pathways for the activation of the transcription factor NF-kB. This inhibition plays a crucial role in suppressing virus multiplication, and the patent also explores the local administration of these ingredients to hinder viral replication. Furthermore, the patent suggests combining these active ingredients with other antivirally effective substances for enhanced prophylaxis or therapy.
Career Highlights:
Oliver Planz's career has been marked by significant contributions to the medical field, particularly in the realm of viral disease treatment. Known for his expertise in MEK inhibitors and their potential therapeutic effects, Planz has been instrumental in designing innovative approaches to combat viral infections. His research and inventions have garnered recognition for their potential to revolutionize the treatment of virus-related diseases.
Collaborations:
Throughout his career, Oliver Planz has collaborated with various renowned entities to further his research and drive innovation in viral disease treatment. Notable among his collaborations are Atriva Therapeutics GmbH and Activaero GmbH. These partnerships have allowed him to leverage resources and expertise to advance his inventions and bring them closer to practical implementation. Collaborating with esteemed colleagues, such as Stephan Pleschka and Stephan Ludwig, has enabled Planz to tap into a diverse range of scientific perspectives and enrich his work.
Conclusion:
Oliver Planz's exceptional contributions to the field of viral disease treatment have made him a key figure in medical innovation. Through his patents concerning MEK inhibitors, he has shown great potential in paving the way towards more effective prevention and treatment of viral infections. Planz's collaborations with renowned organizations reflect his dedication to pushing the boundaries of medical research. As we eagerly await further developments in his work, Oliver Planz continues to inspire future innovators in the fight against viral diseases.
Disclaimer: The information presented in this article is based on the available data about Oliver Planz. For more accurate and up-to-date details, please refer to official sources and publications.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.